From the same participant

1. Does the glucagon-like peptide-1 receptor agonist semaglutide prevent deterioration of metabolic state in prediabetic or diabetic patients with schizophrenia treated with the antipsychotic compounds clozapine or olanzapine?

   Project: Types of projects › Project

2. Kan behandling med psilocybin reducere indtaget af alkohol hos patienter med diagnosen alkoholafhængighed?

   Project: Types of projects › Project

3. BrainDrugs WP4 Depression: Prædiktorer for behandlingsrespons ved depression

   Project: Types of projects › Project

4. Serotonergic Neurotransmission in Schizophrenia

   Project: Types of projects › Project

5. Virtual Reality-assisteret eksponeringsterapi til patienter med alkoholafhængighed: Et randomiseret klinisk studie

   Project: Types of projects › Project

6. Does Glucagon-like Peptide 1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence?

   Project: Types of projects › Project

7. Forudsigelse af effekten af medicinsk behandling af depression NEUROPHARM 1

   Project: Types of projects › Project

8. Glycine reuptake inhibitors as a novel treatment strategy in alcohol abuse disorders

   Project: Types of projects › Project

9. The Role of Muscarinic Receptors in Alcohol use Disorder

   Project: Types of projects › Project

10. The role of muscarinic receptors in sucrose intake.

    Project: Types of projects › Project